[PDF][PDF] Combined oral contraceptives containing dienogest and estradiol valerate may carry a lower risk of venous and arterial thromboembolism compared to …
J Dinger, S Möhner, K Heinemann - Front Womens Health, 2020 - zeg-berlin.de
Objectives: The previously reported initial results of the International Active Surveillance
study “Safety of Contraceptives: Role of Estrogens”(INAS-SCORE) suggested that the risks …
study “Safety of Contraceptives: Role of Estrogens”(INAS-SCORE) suggested that the risks …
[PDF][PDF] COCs containing dienogest and 30 µg ethinylestradiol may carry a higher VTE risk compared to corresponding preparations with levonorgestrel: a meta …
J Dinger - Front Womens Health, 2020 - zeg-berlin.de
Abstract Background: The European Medicines Agency requested a meta-analysis of four
large, multi-national cohort studies on hormonal contraceptives to clarify whether dienogest …
large, multi-national cohort studies on hormonal contraceptives to clarify whether dienogest …
Impact of estrogen type on cardiovascular safety of combined oral contraceptives
J Dinger, T Do Minh, K Heinemann - Contraception, 2016 - Elsevier
Abstract Objectives The International Active Surveillance study “Safety of Contraceptives:
Role of Estrogens”(INAS-SCORE) investigated the cardiovascular risks associated with the …
Role of Estrogens”(INAS-SCORE) investigated the cardiovascular risks associated with the …
Confirmation of the safety of combined oral contraceptives containing oestradiol on the risk of venous thromboembolism
G Grandi, F Facchinetti, J Bitzer - The European Journal of …, 2022 - Taylor & Francis
Hormonal contraceptives, in particular combined oral contraceptives (COCs), were designed
to avoid unintended pregnancy, with the fewest possible side effects and health risks. The …
to avoid unintended pregnancy, with the fewest possible side effects and health risks. The …
Prospective controlled cohort study on the safety of a monophasic oral contraceptive containing nomegestrol acetate (2.5 mg) and 17β-oestradiol (1.5 mg)(PRO-E2 …
S Reed, C Koro, J DiBello, K Becker… - … European Journal of …, 2021 - Taylor & Francis
Objective To assess and compare the risk of venous thromboembolism (VTE) and arterial
thromboembolism (ATE) in NOMAC-E2 users with levonorgestrel-containing combined oral …
thromboembolism (ATE) in NOMAC-E2 users with levonorgestrel-containing combined oral …
Combined oral contraceptives containing estradiol valerate vs ethinylestradiol on coagulation: a randomized clinical trial
AH Haverinen, KM Luiro, T Szanto… - Acta Obstetricia et …, 2022 - Wiley Online Library
Introduction Contraceptives containing ethinylestradiol (EE) induce changes in the
coagulation system and are associated with a risk of venous thromboembolism. However …
coagulation system and are associated with a risk of venous thromboembolism. However …
[HTML][HTML] A systematic review and meta‐analysis of venous thrombosis risk among users of combined oral contraception
MV Dragoman, NK Tepper, R Fu… - … of Gynaecology and …, 2018 - ncbi.nlm.nih.gov
Background Combined oral contraceptives (COC s) containing various progestogens could
be associated with differential risks for venous thromboembolism (VTE). Objective To …
be associated with differential risks for venous thromboembolism (VTE). Objective To …
Systematic review and meta-analysis of the association of combined oral contraceptives on the risk of venous thromboembolism: the role of the progestogen type and …
C Oedingen, S Scholz, O Razum - Thrombosis research, 2018 - Elsevier
Introduction Currently available combined oral contraceptives (COC) reportedly increase the
risk of venous thromboembolism (VTE). We aimed to quantify this risk considering both …
risk of venous thromboembolism (VTE). We aimed to quantify this risk considering both …
Efficacy and bleeding profile of a combined oral contraceptive containing oestradiol valerate/dienogest: a pooled analysis of three studies conducted in North America …
A Nelson, S Parke, D Makalova, M Serrani… - … European Journal of …, 2013 - Taylor & Francis
Objective To summarise all clinical data on the contraceptive efficacy and bleeding profile
associated with an oestradiol valerate (E2V) and dienogest (DNG)[E2V/DNG] combined oral …
associated with an oestradiol valerate (E2V) and dienogest (DNG)[E2V/DNG] combined oral …
Venous thrombosis and hormonal contraception: what's new with estradiol-based hormonal contraceptives?
F Fruzzetti, A Cagnacci - Open access journal of contraception, 2018 - Taylor & Francis
Objective Estradiol (E2)-based hormonal contraceptives impact less than ethinylstradiol (EE)
contraceptives on venous thromboembolism (VTE) in comparison to formulations with EE …
contraceptives on venous thromboembolism (VTE) in comparison to formulations with EE …